Muscular Dystrophy Clinical Trials

A listing of Muscular Dystrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1095 clinical trials
COVID19 and Physical and Emotional Wellbeing of HCP

The current COVID-19 pandemic has affected more than 3 million people worldwide across more than 200 countries. In the United Kingdom alone, at the end of April, there were almost 160,000 confirmed cases with more than 20,000 deaths. This has undoubtedly had significant physical and economical impact on the public. …

covid-19
depression
anxiety
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

The objective of this project is to validate the sensitivity, specificity, positive predictive value and negative predictive values of the AMRA blood test for assessing risk of cancer in women at high risk for ovarian cancer, due to the presence of a symptomatic adnexal mass.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Using Deep Learning Methods to Analyze Automated Breast Ultrasound Images to Establish a Diagnosis Therapy Assessment and Prognosis Prediction Model of Breast Cancer.

The purpose of this study is using a deep learning method to analyze the automated breast ultrasound (ABUS) imagings, establish and evaluate a diagnosis, therapy assessment and prognosis prediction model of breast cancer. The model would provide important references for further early prevention, early diagnosis and personalized treatment.

ultrasound breast
early detection
  • 0 views
  • 19 Feb, 2024
  • 1 location
Comparative Effectiveness of Targeted Therapy in RA Patients

The objective of a multicenter prospective observational study is to compare effectiveness and safety of biologic disease-modifying antirheumatic drugs and small molecular inhibitors in patients with moderately to severely active rheumatoid arthritis patients who have had an inadequate response or intolerace to methotrexate.

disease modifying antirheumatic drugs
antirheumatics
etanercept
DMARD
abatacept
  • 0 views
  • 19 Feb, 2024
  • 1 location
Proton Radiation Therapy Registry

The Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The goal is to have all patients treated at the proton center to be included in the registry …

  • 0 views
  • 19 Feb, 2024
  • 4 locations
The Diabetic Retinopathy Screening Prevention and Control Program

The greatest harm of diabetes is various acute and chronic complications, especially diabetic retinopathy(DR), leading to extremely high rates of disability and blindness. Early screening, early diagnosis, and early treatment are the keys to maintaining vision in patients with DR. However, compared with the high prevalence of diabetes in China, …

diabetes
acromegaly
diabetic retinopathy screening
retinopathy
type 2 diabetes mellitus
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV

In COVID-19 pandemic, it is of critical importance to identify a rapid and simple diagnostic method to be used in clinical settings to timely inform and refine strategies that can prevent, control, and stop the spread of SARS-CoV-2. The 2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a qualitative, membrane-based …

cancer
PCR test
myalgia
immunoglobulins
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 5 locations
EP Device Registry

This study will provide ongoing, high quality data on the safety, performance, and clinical benefits of Abbott's EP devices in a real-world setting.

diagnostic procedure
  • 0 views
  • 19 Feb, 2024
  • 3 locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

datscan
resting tremor
tremor
modafinil
methyldopa
  • 0 views
  • 19 Feb, 2024
  • 46 locations
Development of Systems and Precision Medicine - Take Mood Disorder as an Example.

Precision medicine is to achieve individual optimal health care, given the biological mechanisms, genetic variants, and environmental measurements. Take mood disorder (MD) as an example, we aim to develop systems and precision medicine in Taiwanese population. MD is a very serious and dysfunctional mental disorder.

precision medicine
mood disorder
psychiatric disorder
microbiota
antidepressants
  • 0 views
  • 19 Feb, 2024
  • 1 location